Introduction
============

The global incidence of esophageal cancer has increased by 50% in the past two decades.[@b1-ott-6-119],[@b2-ott-6-119] Advances in neoadjuvant and adjuvant chemotherapy and chemoradiotherapy have led to increasingly multimodal treatment for patients with esophageal cancer, which has decreased the rate of local recurrence and improved long-term survival for some patients. However, surgical resection with radical lymphadenectomy is regarded as one of the curative options for resectable esophageal cancer.[@b3-ott-6-119]--[@b6-ott-6-119] Frequently, due consideration of surgical resection may not be given because of concerns with regard to the morbidity of open esophagectomy.

In an effort to decrease the morbidity associated with open esophagectomy, Chinese surgeons have adopted a minimally invasive approach to esophageal resection. Because of the potential advantages, including avoiding thoracotomy and laparotomy and reducing the rate of pulmonary infections (thus reducing the inpatient stay),[@b7-ott-6-119],[@b8-ott-6-119] minimally invasive esophagectomy (MIE) was introduced into clinical practice in Taiwan[@b9-ott-6-119] in 1992 at the same time as in Western countries,[@b10-ott-6-119]--[@b12-ott-6-119] was gradually implemented, and is now a commonplace procedure in the People's Republic of China ([Figure 1](#f1-ott-6-119){ref-type="fig"}), including in Beijing,[@b13-ott-6-119]--[@b15-ott-6-119] Jinan in Shandong Province,[@b16-ott-6-119] Zhengzhou in Henan Province,[@b17-ott-6-119] Nanjing in Jiangsu Province,[@b18-ott-6-119] Shanghai,[@b19-ott-6-119]--[@b30-ott-6-119] Taizhou in Zhejiang Province,[@b31-ott-6-119]--[@b33-ott-6-119] Fuzhou in Fujian Province,[@b34-ott-6-119]--[@b36-ott-6-119] Taipei[@b9-ott-6-119] and Taichung[@b37-ott-6-119] in Taiwan, Hongkong,[@b38-ott-6-119]--[@b40-ott-6-119] Guangzhou in Guangdong Province,[@b41-ott-6-119],[@b42-ott-6-119] Changsha in Hunan Province,[@b43-ott-6-119] Chongqing,[@b44-ott-6-119],[@b45-ott-6-119] and Chengdu[@b46-ott-6-119]--[@b48-ott-6-119] and Nanchong[@b49-ott-6-119] in Sichuan Province. There has been burgeoning interest in MIE since it was first described in Taiwan in 1995[@b9-ott-6-119] and in the People's Republic of China in 1999.[@b13-ott-6-119] The last decade has witnessed nationwide growth in use of MIE, yielding a significant amount of scientific data to support its clinical merits and advantages. Here we review the current data and state of the art for MIE in the treatment of esophageal cancer in the People's Republic of China.

Literature on MIE in the People's Republic of China
===================================================

The current literature was reviewed by searching the PubMed/Medline database from January 1992 to December 2012 using keywords such as "minimally invasive oesophagectomy", "MIE", and "China". Sixty-one full articles were found to be relevant to MIE ([Figure 2](#f2-ott-6-119){ref-type="fig"}). A total of 33 publications (54.1%) were in English. However, nearly half of all relevant clinical reports (28, 45.9%) were published in Chinese, despite the fact that it has been necessary to report the current status of MIE as performed in the People's Republic of China to cardiothoracic surgeons worldwide. A marked increase in the number of papers dedicated to MIE was observed from 2010 to 2012 ([Figure 2](#f2-ott-6-119){ref-type="fig"}), which probably reflects increased research interest among the surgical community and wider clinical application of this patient-friendly approach.

Operative data on MIE
=====================

Key outcomes of the major studies are summarized in the [Tables 1](#t1-ott-6-119){ref-type="table"} and [2](#t2-ott-6-119){ref-type="table"}. Thirty-two relevant papers, consisting of prospective and retrospective studies, were identified. Eight papers directly compared open oesophagectomy and MIE, and[@b16-ott-6-119],[@b17-ott-6-119],[@b21-ott-6-119],[@b30-ott-6-119],[@b31-ott-6-119],[@b39-ott-6-119],[@b41-ott-6-119],[@b48-ott-6-119] five of these involved studies performed prospectively.[@b16-ott-6-119],[@b31-ott-6-119],[@b39-ott-6-119],[@b41-ott-6-119],[@b48-ott-6-119] Common outcome measures included operative data (operative time, blood loss, conversion rate), morbidity (duration of intensive care and total hospital stay), complications (pulmonary complications, anastomotic leaks, chylothorax), mortality data, and follow-up periods. Neoadjuvant treatment numbers were included for each study.

Surgical approaches
-------------------

Surgical approaches for MIE performed by Chinese cardiothoracic surgeons are multiple and complicated. As listed in [Table 1](#t1-ott-6-119){ref-type="table"}, the majority of centers use mainly total MIE (laparoscopic and thoracoscopic esophagectomy), whereas hybrid MIE (thoracoscopy and laparotomy/laparoscopy and thoracotomy) is used in routine practice in some centers. At our center, we originally used hybrid MIE[@b31-ott-6-119] but more recently transitioned to a minimally invasive modified McKeown 3-incision total MIE (laparoscopic and thoracoscopic esophagectomy) in 2010.[@b32-ott-6-119],[@b33-ott-6-119]

Operative time and blood loss
-----------------------------

Operative time varied significantly between the studies, reflecting the type of MIE performed as well as accumulated experience and technical skills ([Table 1](#t1-ott-6-119){ref-type="table"}). Blood loss also varied significantly from center to center, comprising around 100--700 mL ([Table 1](#t1-ott-6-119){ref-type="table"}). Major blood loss and need for blood transfusion in particular increased the risk of postoperative morbidity and mortality.

Conversion to open esophagectomy
--------------------------------

The conversion rate reported in the literature is in a range of 0%--9.7% ([Table 1](#t1-ott-6-119){ref-type="table"}). However, with surgical experience, the conversion rate reduces and currently does not exceed 5% in expert centers in the People's Republic of China. The main reason for conversion was bleeding. It is not appropriate to consider conversion from MIE to open esophagectomy as a failure because patient safety and the oncologic integrity of the procedure should be of supreme importance.

Mortality, morbidity, and postoperative complications
-----------------------------------------------------

Mortality rates following total MIE vary between 0% and 7.7% ([Table 2](#t2-ott-6-119){ref-type="table"}), which compares favorably with an open transthoracic procedure mortality rate of 9.2% and an open transhiatal procedure mortality rate of 7.2%.[@b50-ott-6-119] However, at least half of the patients who undergo open oesophagectomy, performed through a right thoracotomy and laparotomy, are at risk of developing pulmonary complications requiring a protracted stay in intensive care, with consequences for quality of life during convalescence.[@b50-ott-6-119] Anastomotic leak is one of the most feared complications of MIE. From the operative data, the MIE leakage rate was in the range of 0%--20.8% ([Table 2](#t2-ott-6-119){ref-type="table"}), which is comparable with the leakage rates reported for open oesophagectomy.[@b51-ott-6-119] Median duration of postoperative stay in intensive care following MIE was one day in the majority of studies ([Table 2](#t2-ott-6-119){ref-type="table"}). MIE is associated with a significant reduction in hospital stay, with a mean postoperative stay of 12 days ([Table 2](#t2-ott-6-119){ref-type="table"}).

Outcomes
--------

There is little survival data for MIE available in the People's Republic of China. Only one study reported overall survival after MIE.[@b25-ott-6-119] Feng et al reported median survival for patients in a thoracoscope-assisted transthoracic esophagectomy group and in a mediastinoscope-assisted transhiatal esophagectomy group of 34.4 months and 36.8 months, respectively.[@b25-ott-6-119] There do not appear to be any prospective, randomized, controlled trials comparing the oncologic outcome of MIE with that of open esophagectomy. The present knowledge is based mainly on short-term, nonrandomized comparative studies or historical comparisons with outcomes of open surgery.[@b31-ott-6-119],[@b39-ott-6-119],[@b41-ott-6-119],[@b48-ott-6-119]

Conclusion
==========

In conclusion, MIE is becoming more popular in the People's Republic of China now that Chinese cardiothoracic surgeons are receiving adequate training in major centers. Use of the technique is growing in the People's Republic of China, as confirmed by the increasing number of recently published papers on MIE. However, no prospective, randomized, controlled trials have investigated the benefits of MIE in this country. Such trials, directly comparing MIE and open approaches, are urgently needed.
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###### 

Survey over major reports of minimally invasive esophagectomy in the People's Republic of China: operative data

  Reference                     PS/RS   Patient (n)                                   AC     TC   AS                   Position                       OT (min)         BL (mL)           C, n (%)
  ----------------------------- ------- --------------------------------------------- ------ ---- -------------------- ------------------------------ ---------------- ----------------- ----------
  Liu et al[@b9-ott-6-119]      RS      20                                            Open   MI   Thoracic             Left Lateral                   280              250               NA
  Li et al[@b14-ott-6-119]      PS      6                                             MI     MI   Thoracic             Left Lateral                   260 ± 42         520 ± 160         0
  Li et al[@b15-ott-6-119]      RS      6                                             MI     MI   Thoracic             Left Lateral                   380              300               0
  Du et al[@b16-ott-6-119]      PS      45                                            Open   HA   Cervical/ thoracic   Left Lateral                   29 ± 5 (TC)      93 ± 19 (TC)      NA
                                        27                                            Open   MI   Cervical             Left Lateral                   425 (240--538)   400 (100--1200)   1 (4)
  Liu et al[@b17-ott-6-119]     RS      98                                            MI     MI   Cervical             Left Lateral                   134.5 ± 42.3     85.1 ± 32.8       NA
  Hou et al[@b18-ott-6-119]     RS      41                                            MI     MI   Cervical             Prone                          230 (170--310)   275 (100--320)    NA
                                        41                                            MI     MI   Cervical             Left Lateral                   280 (190--380)   360 (120--670)    NA
  Wu et al[@b20-ott-6-119]      PS      32                                            Open   MI   Cervical             Supine                         180              218               0
                                        8                                             MI     MI   Cervical             Supine                         220              100               0
  Zhou et al[@b22-ott-6-119]    PS      30                                            Open   MI   Cervical             Left Lateral                   225 (195--290)   250 ± 52.2        1 (3)
  Tan et al[@b23-ott-6-119]     RS      36                                            Open   MI   Cervical             Left Lateral                   250 (190--330)   165 (100--350)    0
  Wang et al[@b24-ott-6-119]    PS      27                                            MI     MI   Cervical             Left Lateral                   267 ± 51         327 ± 83          NA
  Feng et al[@b25-ott-6-119]    PS      27                                            MI     MI   Cervical             Supine                         194.4 ± 26       215 ± 111.6       0
                                        27                                            MI     MI   Cervical             Left Lateral                   228.1 ± 35.8     142.6 ± 51.3      0
  Wang et al[@b26-ott-6-119]    RS      48[a](#tfn2-ott-6-119){ref-type="table-fn"}   MI     MI   Cervical             Left Lateral                   279 ± 64         359 ± 156         NA
                                        49[b](#tfn3-ott-6-119){ref-type="table-fn"}   MI     MI   Cervical             Left Lateral                   266 ± 56         336 ± 130         NA
  Feng et al[@b27-ott-6-119]    RS      52                                            MI     MI   Cervical             Left Lateral                   82 ± 17 (TC)     139 ± 54 (TC)     0
                                RS      36                                            MI     MI   Cervical             Prone                          70 ± 20 (TC)     100 ± 52 (TC)     0
  Shen et al[@b28-ott-6-119]    RS      76                                            MI     MI   Cervical             Prone                          89 ± 32 (TC)     152 ± 108         0
  Feng et al[@b29-ott-6-119]    PS      41                                            MI     MI   Cervical             Decubitus                      217 ± 32         142 ± 49          1 (2.4)
                                PS      52                                            MI     MI   Cervical             Prone                          202 ± 21         123 ± 56          0
  Wang et al[@b30-ott-6-119]    RS      260                                           MI/O   MI   Cervical             Left Lateral                   105 ± 30 (TC)    95 ± 48 (TC)      NA
  Zhu et al[@b31-ott-6-119]     PS      25                                            Open   MI   Thoracic             Left Lateral                   88 ± 15 (TC)     280 ± 132 (TC)    NA
  Chen et al[@b32-ott-6-119]    PS      67                                            MI     MI   Cervical             Left Lateral                   274 ± 15         225 ± 31          NA
  Zhu et al[@b33-ott-6-119]     PS      11                                            MI     MI   Cervical             Left Lateral                   242.3 ± 27.0     168.2 ± 95.6      NA
  Lin et al[@b34-ott-6-119]     RS      80                                            MI     MI   Cervical             Left Lateral                   NA               100--250          6 (8)
  Liu et al[@b35-ott-6-119]     RS      297                                           MI     MI   Cervical             Left Lateral                   242.3 ± 58.7     NA                1 (3)
  Lin et al[@b36-ott-6-119]     RS      150                                           MI     MI   Cervical             Left Lateral                   258 ± 45         207 ± 130         6 (4)
  Cense et al[@b38-ott-6-119]   PS      30                                            Open   MI   Cervical             Left Lateral                   400 (180--570)   700 (164--3000)   2 (7)
  Law et al[@b39-ott-6-119]     PS      30                                            Open   MI   Thoracic             Left Lateral (29)/ prone (1)   392 (180--570)   700 (164--3000)   2 (6.7)
  Wong et al[@b40-ott-6-119]    PS      12                                            MI     MI   Thoracic             Supine                         510 (300--660)   500 (250--2500)   1 (8)
  Wang et al[@b41-ott-6-119]    PS      33                                            MI     MI   Cervical             Na                             NA               NA                NA
  Xie et al[@b42-ott-6-119]     RS      100                                           MI     MI   Cervical             Left Lateral                   310              200               4 (4)
  Yuan et al[@b43-ott-6-119]    PS      32                                            MI     MI   Cervical             Left Lateral                   290.8 ± 36.9     NA                NA
                                        36                                            Open   MI   Cervical             Supine                         249.0 ± 31.0     NA                NA
  Guo et al[@b44-ott-6-119]     RS      89                                            Open   MI   Cervical             Left Lateral                   323.7 ± 50.3     307.8 ± 162.7     8 (9.0)
  Guo et al[@b45-ott-6-119]     RS      135                                           Open   MI   Cervical             Left Lateral                   334 ± 51.1       349.3 ± 164.8     10 (7.4)
  Zhang et al[@b46-ott-6-119]   RS      160                                           MI     MI   Cervical             Prone                          230--780         20--4000          9 (5.6)
  Gao et al[@b48-ott-6-119]     PS      96                                            MI     MI   Cervical             Left Lateral                   330.2 ± 36.7     346.7 ± 41.1      0

**Notes:**

Retrosternal route of gastric tube reconstruction;

prevertebral route of gastric tube reconstruction.

**Abbreviations:** PS, prospective study; RS, retrospective study; AC, abdominal component; TC, thoracic component; AS, anastomosis site; OT, operation time; BL, blood loss; C, conversion rate; MI, minimally invasive; O, open; NA, not available; HA, hand-assisted.

###### 

Survey of major reports of minimally invasive esophagectomy in the People's Republic of China: mortality, morbidity, and postoperative complications

  Reference                     Patient (n)   AL, n (%)   PC, n (%)   Ch, n (%)   ICUS (d)     HS (d)        30-DM     Mortality, n (%)   FP (m)
  ----------------------------- ------------- ----------- ----------- ----------- ------------ ------------- --------- ------------------ ------------
  Liu et al[@b9-ott-6-119]      20            0           0           0           NA           19            NA        NA                 11.5
  Li et al[@b14-ott-6-119]      6             0           NA          NA          0            17            NA        NA                 2.5
  Li et al[@b15-ott-6-119]      6             0           0           0           NA           NA            NA        NA                 NA
  Du et al[@b16-ott-6-119]      45            NA          NA          NA          NA           10.0 ± 1.0    NA        NA                 NA
  Liu et al[@b17-ott-6-119]     98            2 (2.0)     10 (10.2)   3 (3.1)     NA           12.7 ± 3.5    1         NA                 NA
  Hou et al[@b18-ott-6-119]     41            1 (2.4)     2 (4.9)     0           NA           NA            NA        NA                 15.7
                                41            1 (2.4)     1 (2.4)     2 (4.9)     NA           NA            NA        NA                 16.3
  Wu et al[@b20-ott-6-119]      32            3 (9.4)     1 (3.1)     1 (3.1)     2.2          11.6          NA        NA                 NA
                                8             1 (12.5)    0           0           1.2          10.6          NA        NA                 NA
  Zhou et al[@b22-ott-6-119]    30            2 (6.7)     2 (6.7)     1 (3.3)     NA           11.7 ± 6.3    0         0                  NA
  Tan et al[@b23-ott-6-119]     36            5 (13.9)    1 (2.8)     1 (2.8)     NA           8.7           0         0                  NA
  Wang et al[@b24-ott-6-119]    27            5 (18.5)    1 (3.7)     2 (7.4)     2.3 ± 1.7    NA            NA        NA                 NA
  Feng et al[@b25-ott-6-119]    27            5 (18.5)    7 (25.9)    0           3.1 ± 4.4    11.1 ± 6.6    1         NA                 36
                                27            4 (14.8)    4 (14.8)    1 (3.7)     1.9 ± 4.2    13.3 ± 10.6   0         NA                 36
  Wang et al[@b26-ott-6-119]    48            10 (20.8)   2 (4.2)     1 (2.1)     2.5 ± 1.7    NA            0         NA                 NA
                                49            3 (6.1)     6 (12.2)    1 (2.0)     2.8 ± 1.9    NA            0         NA                 NA
  Feng et al[@b27-ott-6-119]    52            8 (15.4)    5 (9.6)     2 (3.8)     1.3 ± 3.5    13.6 ± 9.3    NA        NA                 NA
                                36            2 (5.6)     1 (2.8)     0           1.1 ± 1.5    10.9 ± 6.0    NA        NA                 NA
  Shen et al[@b28-ott-6-119]    76            16 (21.1)   5 (6.6)     1 (1.3)     NA           19.2 ± 16.3   NA        0                  NA
  Feng et al[@b29-ott-6-119]    41            9 (22.0)    4 (9.8)     NA          3.5 ± 1.3    17.4 ± 12.5   NA        NA                 NA
                                52            4 (7.7)     5 (9.6)     NA          1.5 ± 1.1    11.4 ± 6.8    NA        NA                 NA
  Wang et al[@b30-ott-6-119]    260           26 (10)     22 (8.5)    3 (1.2)     NA           14.3 ± 7.5    NA        2 (7.7)            NA
  Zhu et al[@b31-ott-6-119]     25            1 (4)       NA          NA          NA           10.9 ± 2.5    NA        NA                 NA
  Chen et al[@b32-ott-6-119]    67            NA          7 (10.4)    NA          NA           11.5 ± 1.6    NA        NA                 14.0 ± 2.2
  Zhu et al[@b33-ott-6-119]     11            2 (18.2)    3 (27.3)    NA          NA           18.9 ± 10.3   NA        NA                 4.5
  Lin et al[@b34-ott-6-119]     80            1 (1.3)     NA          2 (2.5)     NA           NA            NA        NA                 NA
  Liu et al[@b35-ott-6-119]     297           9 (3.0)     41 (18.8)   NA          NA           17.4 ± 9.8    NA        NA                 NA
  Lin et al[@b36-ott-6-119]     150           9 (6.0)     17 (11.3)   5 (3.3)     NA           NA            2 (1.3)   9 (6)              3--22
  Cense et al[@b38-ott-6-119]   30            1 (3.3)     12 (40)     NA          NA           NA            NA        NA                 NA
                                27            1 (3.7)     13 (48.1)   NA          NA           NA            NA        2 (7)              NA
  Law et al[@b39-ott-6-119]     30            1 (3.3)     12 (40)     0           NA           NA            1         NA                 NA
  Wong et al[@b40-ott-6-119]    12            1 (8.3)     2 (17)      NA          2            41            0         0                  NA
  Wang et al[@b41-ott-6-119]    33            1 (3.0)     0           0           NA           NA            NA        NA                 NA
  Xie et al[@b42-ott-6-119]     100           11 (11)     13 (13)     3 (3)       1 (1)        12 (12)       NA        NA                 NA
  Yuan et al[@b43-ott-6-119]    32            2 (6.3)     NA          NA          1            11.1 ± 1.3    0         NA                 NA
                                36            5 (13.9)    NA          NA          1            11.6 ± 1.7    0         NA                 NA
  Guo et al[@b44-ott-6-119]     89            6 (6.7)     4 (4.5)     4 (4.5)     NA           15.2 ± 9.8    NA        NA                 NA
  Guo et al[@b45-ott-6-119]     135           9 (6.7)     7 (5.2)     8 (5.9)     NA           NA            NA        NA                 NA
  Zhang et al[@b46-ott-6-119]   160           21 (13.1)   25 (15.6)   4 (2.5)     1            13.1          2 (1.3)   4 (2.5)            NA
  Gao et al[@b48-ott-6-119]     96            7 (7.3)     13 (13.5)   1 (1.1)     19.2 ± 3.5   12.6 ± 8.8    NA        2 (2.1)            NA

**Abbreviations:** AL, anastomotic leaks; PC, pulmonary complication; Ch, chylothorax; ICUS (d), intensive care unit stay (days); HS (d), hospital stay (days); 30-DM, 30-day mortality; FP (m), follow-up period (months); NA, not available.
